Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

Donald Trump & Bristol Myers Squibb

6 shared events · Importance 3 · Last updated Aug 03, 2026

Importance
3
Shared Events
6
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
55
Business
Donald Trump: Donald Trump's administration has prioritized domestic investment, and AstraZeneca has already committed $50 billion to US manufacturing. The merger would likely need approval from his antitrust authorities.
Bristol Myers Squibb: Bristol Myers Squibb is the target of the potential merger, which would provide it with a significant premium and access to AstraZeneca's pipeline. Its shares have risen 43% in the past year, and the deal could further boost its valuation.
Aug 02, 2026 · 60 articles
52
Regulatory
Donald Trump: The President could weigh in on the draft rules, which remain subject to change, and is due to meet Xi Jinping next week.
Bristol Myers Squibb: Bristol Myers Squibb signed a partnership with Jiangsu Hengrui worth up to $15.2 billion this year, a deal type the draft rules would likely preserve.
Sep 18, 2026 · 6 articles
42
Business
Donald Trump: Held off on strikes against Iran, easing oil prices. Pushed for lower rates.
Bristol Myers Squibb: Reportedly in merger talks with AstraZeneca, which could create a $400 billion drugmaker.
Jul 14, 2026 · 280 articles
29
International
Donald Trump: US President whose rejection of global AI controls at the same UN event directly counters Burnham's initiative, signaling continued US light-touch AI policy that favors domestic tech firms.
Bristol Myers Squibb: Christopher Boerner attended Burnham's business event; no direct impact.
Sep 22, 2026 · 22 articles
0
Regulatory
Dec 19, 2025 · 7 articles
0
Regulatory
Bristol Myers Squibb: Bristol Myers Squibb is one of the major drugmakers that has reached pricing agreements with the Donald Trump administration to avoid the new tariffs.
Apr 02, 2026 · 23 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Donald Trump and Bristol Myers Squibb interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.